Peringkat dalam Saham
#27744
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Kapitalisasi Pasar
$30.83M
Perubahan (1 tahun)
-61.85%
Perdagangan IMBdx (461030)
Harga 461030 dengan kapitalisasi pasar B
Kapitalisasi pasar dari IMBdx(461030)
Kapitalisasi Pasar: $30.83M
Per August 2026, IMBdx memiliki kapitalisasi pasar sebesar $30.83M. Ini menjadikan IMBdx sebagai perusahaan 27744th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar IMBdx dari 2024 hingga 2026
461030 dibandingkan dengan 5 teratas stocks paling populer
| Harga 461030 |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.301T
|
+17,194,305.67%
|
|
|
|
|
$4.634T
|
+15,030,760.60%
|
|
|
|
|
$4.143T
|
+13,438,471.30%
|
|
|
|
|
$3.589T
|
+11,642,735.00%
|
|
|
|
|
$2.857T
|
+9,266,973.61%
|
